Literature DB >> 18981455

Management of tumor lysis syndrome: need for evidence-based guidelines.

James H Feusner, A Kim Ritchey, Susan L Cohn, Amy L Billett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18981455     DOI： 10.1200/JCO.2008.19.6030

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 2.  The safety and side effects of monoclonal antibodies.

Authors:  Trevor T Hansel; Harald Kropshofer; Thomas Singer; Jane A Mitchell; Andrew J T George
Journal:  Nat Rev Drug Discov       Date:  2010-03-22       Impact factor: 84.694

Review 3.  Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.

Authors:  Jennifer Dinnel; Bonny L Moore; Brent M Skiver; Prithviraj Bose
Journal:  Core Evid       Date:  2015-01-13

4.  Letter to the editor.

Authors:  Vito D'Alessandro; Mario Greco
Journal:  J Blood Med       Date:  2012-08-03

5.  Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report.

Authors:  C Baudon; F P Duhoux; I Sinapi; J L Canon
Journal:  J Med Case Rep       Date:  2016-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.